Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Massachusetts for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Massachusetts only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Massachusetts (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Tina Cleary (NPI 1649243221)

Field	Value
Entity Type	Individual
Organization	Tina Cleary
Address	50 Staniford St
City	Boston
State	MA
ZIP	02114
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	February 13, 2006

Payer Source	Total Paid
Medicare	$2.8M
Medicaid	$0

Key Findings

Practice profile and service mix: Medicare billing is concentrated in retina-focused ophthalmology procedures and anti-VEGF intravitreal injections, consistent with the provider taxonomy of Retina Specialist. The top-billed drug code is J0178 (aflibercept), supported by related procedural codes such as 67028 (intravitreal injection) and imaging/diagnostic codes like 92134 (retinal imaging), indicating a clinic workflow centered on injection-based retinal disease management and follow-up imaging.

Revenue concentration: This provider’s Medicare revenue totals $2.8M and is highly concentrated in a small set of drug and procedure codes — the precomputed top 3 Medicare codes by revenue account for 86.1% of total Medicare revenue. In particular, J0178 alone represents $1.7M (59.2% of Medicare revenue) and J2777 contributes $596.8K (21.2%), so injectable therapeutics dominate the revenue base.

Single-payer footprint: The provider effectively operates as a Medicare-centric biller with no Medicaid revenue on file. With Medicare revenue of $2.8M and “none” recorded for Medicaid, payer mix is functionally single-payer Medicare for the periods captured in the dataset, which has implications for reimbursement exposure and network contracting focus.

Competitive standing on leading drug codes: Volume and rank data position the provider as a typical to above-typical participant rather than a national leader for major drugs. For J0178 (aflibercept) the provider ranks #351 of 3204 (89th percentile) described as typical/unremarkable volume, while for J2777 (faricimab) the provider ranks #507 of 2039 (75th percentile) also characterized as typical; these percentiles suggest solid clinical throughput but not dominance among retina specialists nationally.

Statistical outliers in non-drug services: Some non-drug services show unusually high national volumes relative to peers. 92014 (comprehensive established eye exam) ranks in the 98th percentile and is labeled an “extreme outlier, far above typical national volume,” and 92134 (computerized retinal imaging) ranks in the 99th percentile also labeled an “extreme outlier.” These high percentiles indicate substantially greater use of exam and imaging visits compared with most ophthalmologists nationally, consistent with an imaging- and follow-up–intensive retina practice.

Low Medicaid presence and market implications: The absence of Medicaid billing suggests limited exposure to Medicaid populations and may reflect a private-pay/Medicare patient mix or contracting choices. For payer or provider analysts, this single-payer orientation implies pricing and access negotiations will be driven by Medicare reimbursement dynamics rather than in-state Medicaid rates or utilization patterns.

Operational implications from code mix: The dominance of high-cost injectable drug codes (J0178 and J2777) together with frequent retinal imaging (92134) and relatively high volumes of established patient comprehensive exams (92014) suggest a practice model built on recurring, treatment-driven visits (injection cycles) with routine imaging surveillance. This pattern signals predictable, recurring revenue streams tied to anti-VEGF and related biologic therapy schedules.

Tenure and stability: The provider’s NPI was enumerated on 2006-02-13 (roughly 20 years ago), indicating long-standing Medicare enrollment. This tenure supports interpretation of the billing profile as an established practice rather than a short-term or newly enumerated clinic and may correlate with sustained referral patterns and patient panel stability.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

17 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,420	$690	$1.7M
J2777	Injection, faricimab‑svoa, 0.1 mg	20,580	$30	$596.8K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,670	$100	$158.9K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,420	$90	$133.3K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,350	$30	$103.9K
J2778	Injection, ranibizumab, 0.1 mg	330	$180	$60.1K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	480	$70	$32.3K
92004	The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits.	180	$110	$19.8K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	270	$70	$18.4K
J9035	Injection, bevacizumab, 10 mg	340	$50	$18.3K

Showing 1–10 of 17

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Massachusetts Distribution

Tina Cleary — 2 of 17 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Massachusetts

Full comparison — all codes billed, vs. state median

17 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	10	90	790	$690	$826.5K
J2777	10	50	7,080	$30	$343.1K
J2778	23	30	560	$180	$200.7K
67028	17	120	570	$100	$80.7K
92014	38	1,070	160	$90	$30.1K
J9035	28	80	250	$50	$19.7K
92012	123	560	90	$70	$12.4K
92134	12	670	70	$30	$10.6K
99213	776	13,700	70	$60	$8.8K
92004	49	890	40	$100	$6.3K

Showing 1–10 of 17

Related Providers

Other providers that share a Tax Identification Number (TIN) with Tina Cleary, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
The General Hospital Corporation	MA	General Acute Care Hospital	$0	$438M
Community Physicians Of Indiana Inc	IN	Family Medicine Physician	$0	$185M
Massachusetts General Physicians Organization Inc	MA	Dermatology Physician	$0	$60.2M
Boston Emergency Physician Foundation, Inc.	MA	Emergency Medicine Physician	$0	$24.3M
Colorado Permanente Medical Group, P.C.	CO	Internal Medicine Physician	$0	$23.2M
David Reed	MA	Retina Specialist (Ophthalmology) Physician	$7.7M	$0
Torsten Wiegand	MA	Retina Specialist (Ophthalmology) Physician	$7.6M	$0
Chirag Shah	MA	Retina Specialist (Ophthalmology) Physician	$5M	$0
Roger Goldberg	CA	Retina Specialist (Ophthalmology) Physician	$4.6M	$0
Miriam Englander-paschalis Ilios	MA	Retina Specialist (Ophthalmology) Physician	$4.5M	$0

Nearby Providers

Other providers in the same ZIP code as Tina Cleary, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Massachusetts Eye And Ear Infirmary	MA	General Acute Care Hospital	$0	$68.1M
Bay Cove Human Services, Inc	MA	Community/Behavioral Health Agency	$630.5K	$36.4M
Jewish Family & Children's Service	MA	Case Management Agency	$0	$12.5M
Commonwealth Of Massachusetts	MA	Case Management Agency	$0	$10.4M
Massachusetts Eye And Ear Associates, Inc.	MA	Ophthalmology Physician	$0	$6.6M
Jeffrey Heier	MA	Retina Specialist (Ophthalmology) Physician	$3.6M	$0
Adam Chin	MA	Ophthalmology Physician	$3.4M	$870
Boston Eye Surgery & Laser Center Trust	MA	Ambulatory Surgical Clinic/Center	$2.1M	$415.8K
Marianeli Rodriguez	MA	Ophthalmology Physician	$2.4M	$0
Scott Brannan	MA	Diagnostic Radiology Physician	$1.8M	$0

Tina Cleary — Billing Profile & Reimbursement Data

Sign up for Tina Cleary — Billing Profile & Reimbursement Data policy alerts

Tina Cleary — Billing Profile & Reimbursement Data

Sign up for Tina Cleary — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References